adrenergic receptor, alpha 1a |
PERGOLIDE |
Adrenergic alpha1A |
85% |
1.93uM |
.781uM |
View
|
adrenergic receptor, beta 3 |
PINDOLOL |
Adrenergic beta3 |
85% |
.088uM |
.066uM |
View
|
androgen receptor |
FLUOROMETHOLONE |
Testosterone |
85% |
1.285uM |
.857uM |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
PIPAMAZINE |
Calcium Channel Type L, Phenylalkylamine |
85% |
1.941uM |
1.887uM |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
PIPAMAZINE |
Calcium Channel Type L, Phenylalkylamine |
85% |
1.941uM |
1.887uM |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
PIPAMAZINE |
Calcium Channel Type L, Phenylalkylamine |
85% |
1.941uM |
1.887uM |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
PIPAMAZINE |
Calcium Channel Type L, Phenylalkylamine |
85% |
1.941uM |
1.887uM |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
PIPAMAZINE |
Calcium Channel Type L, Phenylalkylamine |
85% |
1.941uM |
1.887uM |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
PIPAMAZINE |
Calcium Channel Type L, Phenylalkylamine |
85% |
1.941uM |
1.887uM |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
PIPAMAZINE |
Calcium Channel Type L, Phenylalkylamine |
85% |
1.941uM |
1.887uM |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
PIPAMAZINE |
Calcium Channel Type L, Phenylalkylamine |
85% |
1.941uM |
1.887uM |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
PIPAMAZINE |
Calcium Channel Type L, Phenylalkylamine |
85% |
1.941uM |
1.887uM |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
PIPAMAZINE |
Calcium Channel Type L, Phenylalkylamine |
85% |
1.941uM |
1.887uM |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
PIPAMAZINE |
Calcium Channel Type L, Phenylalkylamine |
85% |
1.941uM |
1.887uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
PIPAMAZINE |
Calcium Channel Type L, Phenylalkylamine |
85% |
1.941uM |
1.887uM |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
PIPAMAZINE |
Calcium Channel Type L, Phenylalkylamine |
85% |
1.941uM |
1.887uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
PIPAMAZINE |
Calcium Channel Type L, Phenylalkylamine |
85% |
1.941uM |
1.887uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
PIPAMAZINE |
Calcium Channel Type L, Phenylalkylamine |
85% |
1.941uM |
1.887uM |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
PIPAMAZINE |
Calcium Channel Type L, Phenylalkylamine |
85% |
1.941uM |
1.887uM |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
PIPAMAZINE |
Calcium Channel Type L, Phenylalkylamine |
85% |
1.941uM |
1.887uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
PIPAMAZINE |
Calcium Channel Type L, Phenylalkylamine |
85% |
1.941uM |
1.887uM |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
PIPAMAZINE |
Calcium Channel Type L, Phenylalkylamine |
85% |
1.941uM |
1.887uM |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
PIPAMAZINE |
Calcium Channel Type L, Phenylalkylamine |
85% |
1.941uM |
1.887uM |
View
|
Protein-tyrosine kinase, Fyn |
MICONAZOLE |
Protein Tyrosine Kinase, Fyn |
85% |
4.16uM |
NoneNone |
View
|
cholinergic receptor, muscarinic 3 |
DEXCHLORPHENIRAMINE |
Muscarinic M3 |
85% |
2.579uM |
.547uM |
View
|
5-hydroxytryptamine (serotonin) receptor 2A |
DIETHYLSTILBESTROL |
Serotonin 5-HT2A |
85% |
4.79uM |
1.369uM |
View
|
progesterone receptor |
DIETHYLSTILBESTROL |
Progesterone |
85% |
4.682uM |
.611uM |
View
|
progesterone receptor |
DIETHYLSTILBESTROL |
Progesterone |
85% |
4.682uM |
.611uM |
View
|
progesterone receptor |
ETHINYLESTRADIOL |
Progesterone |
85% |
1.067uM |
.139uM |
View
|
progesterone receptor |
ETHINYLESTRADIOL |
Progesterone |
85% |
1.067uM |
.139uM |
View
|
insulin receptor |
INSULIN |
Insulin |
85% |
.001932uM |
.001816uM |
View
|
insulin receptor |
INSULIN |
Insulin |
85% |
.001932uM |
.001816uM |
View
|
solute carrier family 28 (sodium-coupled nucleoside transporter), member 3 |
RAPAMYCIN |
Adenosine Transporter |
85% |
1.0848uM |
.3711uM |
View
|
concentrative Na+ nucleoside cotransporter (DBSS) |
RAPAMYCIN |
Adenosine Transporter |
85% |
1.0848uM |
.3711uM |
View
|
solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 |
RAPAMYCIN |
Adenosine Transporter |
85% |
1.0848uM |
.3711uM |
View
|
adenine nucleotide translocase (DBSS) (Non-specific probe) |
RAPAMYCIN |
Adenosine Transporter |
85% |
1.0848uM |
.3711uM |
View
|
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 |
RAPAMYCIN |
Adenosine Transporter |
85% |
1.0848uM |
.3711uM |
View
|
adrenergic receptor, alpha 2a |
AMITRIPTYLINE |
Imidazoline I2, Central |
85% |
1.685uM |
1.123uM |
View
|
adrenergic receptor, alpha 2c (Non-specific probe) |
AMITRIPTYLINE |
Imidazoline I2, Central |
85% |
1.685uM |
1.123uM |
View
|
adrenergic receptor, alpha 1d (Non-specific probe) |
AMITRIPTYLINE |
Adrenergic alpha1D |
85% |
.105uM |
.052uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
TAMOXIFEN |
Calcium Channel Type L, Dihydropyridine |
85% |
8.585uM |
5.519uM |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
TAMOXIFEN |
Calcium Channel Type L, Dihydropyridine |
85% |
8.585uM |
5.519uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
TAMOXIFEN |
Calcium Channel Type L, Dihydropyridine |
85% |
8.585uM |
5.519uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
TAMOXIFEN |
Calcium Channel Type L, Dihydropyridine |
85% |
8.585uM |
5.519uM |
View
|
adrenergic receptor, alpha 2a |
LISURIDE |
Imidazoline I2, Central |
85% |
.001606uM |
.001071uM |
View
|
adrenergic receptor, alpha 2c (Non-specific probe) |
LISURIDE |
Imidazoline I2, Central |
85% |
.001606uM |
.001071uM |
View
|
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
COBALT(II) ACETYLACETONATE |
Protein Tyrosine Kinase, HER2 Receptor |
85% |
3.174uM |
NoneNone |
View
|
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
COBALT(II) ACETYLACETONATE |
Protein Tyrosine Kinase, HER2 Receptor |
85% |
3.174uM |
NoneNone |
View
|
sodium channel, voltage-gated, type I, alpha |
LISURIDE |
Sodium Channel, Site 2 |
85% |
3.975uM |
3.627uM |
View
|
sodium channel, voltage-gated, type IX, alpha |
LISURIDE |
Sodium Channel, Site 2 |
85% |
3.975uM |
3.627uM |
View
|
sodium channel, voltage-gated, type VII, alpha |
LISURIDE |
Sodium Channel, Site 2 |
85% |
3.975uM |
3.627uM |
View
|
amiloride-sensitive cation channel 5, intestinal |
LISURIDE |
Sodium Channel, Site 2 |
85% |
3.975uM |
3.627uM |
View
|
sodium channel, voltage-gated, type III, beta |
LISURIDE |
Sodium Channel, Site 2 |
85% |
3.975uM |
3.627uM |
View
|
sodium channel, voltage-gated, type VIII, alpha polypeptide |
LISURIDE |
Sodium Channel, Site 2 |
85% |
3.975uM |
3.627uM |
View
|
sodium channel, voltage-gated, type XI, alpha |
LISURIDE |
Sodium Channel, Site 2 |
85% |
3.975uM |
3.627uM |
View
|
sodium channel, voltage-gated, type I, beta |
LISURIDE |
Sodium Channel, Site 2 |
85% |
3.975uM |
3.627uM |
View
|
sodium channel, voltage-gated, type 10, alpha polypeptide |
LISURIDE |
Sodium Channel, Site 2 |
85% |
3.975uM |
3.627uM |
View
|
sodium channel, voltage-gated, type IV, alpha polypeptide |
LISURIDE |
Sodium Channel, Site 2 |
85% |
3.975uM |
3.627uM |
View
|
sodium channel, voltage-gated, type V, alpha polypeptide |
LISURIDE |
Sodium Channel, Site 2 |
85% |
3.975uM |
3.627uM |
View
|
sodium channel, voltage-gated, type II, beta |
LISURIDE |
Sodium Channel, Site 2 |
85% |
3.975uM |
3.627uM |
View
|
sodium channel, nonvoltage-gated 1 alpha |
LISURIDE |
Sodium Channel, Site 2 |
85% |
3.975uM |
3.627uM |
View
|
sodium channel, nonvoltage-gated 1 gamma |
LISURIDE |
Sodium Channel, Site 2 |
85% |
3.975uM |
3.627uM |
View
|
sodium channel, nonvoltage-gated 1 beta |
LISURIDE |
Sodium Channel, Site 2 |
85% |
3.975uM |
3.627uM |
View
|
sodium channel, voltage-gated, type 2, alpha 1 polypeptide |
LISURIDE |
Sodium Channel, Site 2 |
85% |
3.975uM |
3.627uM |
View
|
sodium channel, voltage-gated, type XI, alpha |
LISURIDE |
Sodium Channel, Site 2 |
85% |
3.975uM |
3.627uM |
View
|
sodium channel, nonvoltage-gated 1, gamma |
LISURIDE |
Sodium Channel, Site 2 |
85% |
3.975uM |
3.627uM |
View
|
sodium channel, nonvoltage-gated 1, delta |
LISURIDE |
Sodium Channel, Site 2 |
85% |
3.975uM |
3.627uM |
View
|
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) |
LISURIDE |
Sodium Channel, Site 2 |
85% |
3.975uM |
3.627uM |
View
|
sodium channel, nonvoltage-gated 1 alpha |
LISURIDE |
Sodium Channel, Site 2 |
85% |
3.975uM |
3.627uM |
View
|
sodium channel, voltage-gated, type X, alpha |
LISURIDE |
Sodium Channel, Site 2 |
85% |
3.975uM |
3.627uM |
View
|
sodium channel, voltage-gated, type IX, alpha |
LISURIDE |
Sodium Channel, Site 2 |
85% |
3.975uM |
3.627uM |
View
|
sodium channel, voltage gated, type VIII, alpha |
LISURIDE |
Sodium Channel, Site 2 |
85% |
3.975uM |
3.627uM |
View
|
sodium channel, voltage-gated, type VII, alpha |
LISURIDE |
Sodium Channel, Site 2 |
85% |
3.975uM |
3.627uM |
View
|
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) |
LISURIDE |
Sodium Channel, Site 2 |
85% |
3.975uM |
3.627uM |
View
|
sodium channel, voltage-gated, type IV, beta |
LISURIDE |
Sodium Channel, Site 2 |
85% |
3.975uM |
3.627uM |
View
|
sodium channel, voltage-gated, type IV, alpha |
LISURIDE |
Sodium Channel, Site 2 |
85% |
3.975uM |
3.627uM |
View
|
sodium channel, voltage-gated, type III, alpha |
LISURIDE |
Sodium Channel, Site 2 |
85% |
3.975uM |
3.627uM |
View
|
sodium channel, voltage-gated, type II, beta |
LISURIDE |
Sodium Channel, Site 2 |
85% |
3.975uM |
3.627uM |
View
|
sodium channel, voltage-gated, type II, alpha 2 |
LISURIDE |
Sodium Channel, Site 2 |
85% |
3.975uM |
3.627uM |
View
|
sodium channel, voltage-gated, type I, beta |
LISURIDE |
Sodium Channel, Site 2 |
85% |
3.975uM |
3.627uM |
View
|
sodium channel, voltage-gated, type I, alpha |
LISURIDE |
Sodium Channel, Site 2 |
85% |
3.975uM |
3.627uM |
View
|
sodium channel, voltage-gated, type IV, beta |
LISURIDE |
Sodium Channel, Site 2 |
85% |
3.975uM |
3.627uM |
View
|
sodium channel associated protein 1 |
LISURIDE |
Sodium Channel, Site 2 |
85% |
3.975uM |
3.627uM |
View
|
sodium channel associated protein 2 |
LISURIDE |
Sodium Channel, Site 2 |
85% |
3.975uM |
3.627uM |
View
|
sodium channel, voltage-gated, type III, beta |
LISURIDE |
Sodium Channel, Site 2 |
85% |
3.975uM |
3.627uM |
View
|
opioid receptor, sigma 1 |
PROMAZINE |
Sigma1 |
85% |
.271uM |
.114uM |
View
|
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) |
NITRENDIPINE |
CYP450-2C9 Inhibition |
85% |
.3uM |
NoneNone |
View
|
cytochrome P450, family 2, subfamily C, polypeptide 9 |
NITRENDIPINE |
CYP450-2C9 Inhibition |
85% |
.3uM |
NoneNone |
View
|
dopamine receptor D1A |
PROMAZINE |
Dopamine D1 |
85% |
2.464uM |
1.232uM |
View
|
dopamine receptor D1A |
NELFINAVIR |
Dopamine D1 |
85% |
12.935uM |
6.467uM |
View
|
sodium channel, voltage-gated, type VII, alpha |
PAROXETINE |
Sodium Channel, Site 2 |
85% |
2.69uM |
2.454uM |
View
|
amiloride-sensitive cation channel 5, intestinal |
PAROXETINE |
Sodium Channel, Site 2 |
85% |
2.69uM |
2.454uM |
View
|
sodium channel, voltage-gated, type III, beta |
PAROXETINE |
Sodium Channel, Site 2 |
85% |
2.69uM |
2.454uM |
View
|
sodium channel, voltage-gated, type VIII, alpha polypeptide |
PAROXETINE |
Sodium Channel, Site 2 |
85% |
2.69uM |
2.454uM |
View
|
sodium channel, voltage-gated, type XI, alpha |
PAROXETINE |
Sodium Channel, Site 2 |
85% |
2.69uM |
2.454uM |
View
|
sodium channel, voltage-gated, type I, beta |
PAROXETINE |
Sodium Channel, Site 2 |
85% |
2.69uM |
2.454uM |
View
|
sodium channel, voltage-gated, type 10, alpha polypeptide |
PAROXETINE |
Sodium Channel, Site 2 |
85% |
2.69uM |
2.454uM |
View
|
sodium channel, voltage-gated, type IV, alpha polypeptide |
PAROXETINE |
Sodium Channel, Site 2 |
85% |
2.69uM |
2.454uM |
View
|
sodium channel, voltage-gated, type V, alpha polypeptide |
PAROXETINE |
Sodium Channel, Site 2 |
85% |
2.69uM |
2.454uM |
View
|
sodium channel, voltage-gated, type II, beta |
PAROXETINE |
Sodium Channel, Site 2 |
85% |
2.69uM |
2.454uM |
View
|
sodium channel, nonvoltage-gated 1 alpha |
PAROXETINE |
Sodium Channel, Site 2 |
85% |
2.69uM |
2.454uM |
View
|
sodium channel, nonvoltage-gated 1 gamma |
PAROXETINE |
Sodium Channel, Site 2 |
85% |
2.69uM |
2.454uM |
View
|
sodium channel, nonvoltage-gated 1 beta |
PAROXETINE |
Sodium Channel, Site 2 |
85% |
2.69uM |
2.454uM |
View
|
sodium channel, voltage-gated, type 2, alpha 1 polypeptide |
PAROXETINE |
Sodium Channel, Site 2 |
85% |
2.69uM |
2.454uM |
View
|
sodium channel, voltage-gated, type XI, alpha |
PAROXETINE |
Sodium Channel, Site 2 |
85% |
2.69uM |
2.454uM |
View
|
sodium channel, nonvoltage-gated 1, gamma |
PAROXETINE |
Sodium Channel, Site 2 |
85% |
2.69uM |
2.454uM |
View
|
sodium channel, nonvoltage-gated 1, delta |
PAROXETINE |
Sodium Channel, Site 2 |
85% |
2.69uM |
2.454uM |
View
|
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) |
PAROXETINE |
Sodium Channel, Site 2 |
85% |
2.69uM |
2.454uM |
View
|
potassium voltage-gated channel, subfamily H, member 8 |
DROPERIDOL |
Potassium Channel HERG |
85% |
.9272uM |
.7596uM |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 6 |
DROPERIDOL |
Potassium Channel HERG |
85% |
.9272uM |
.7596uM |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 7 |
DROPERIDOL |
Potassium Channel HERG |
85% |
.9272uM |
.7596uM |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
DROPERIDOL |
Potassium Channel HERG |
85% |
.9272uM |
.7596uM |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 5 |
DROPERIDOL |
Potassium Channel HERG |
85% |
.9272uM |
.7596uM |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 3 |
DROPERIDOL |
Potassium Channel HERG |
85% |
.9272uM |
.7596uM |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 4 |
DROPERIDOL |
Potassium Channel HERG |
85% |
.9272uM |
.7596uM |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 1 |
DROPERIDOL |
Potassium Channel HERG |
85% |
.9272uM |
.7596uM |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 1 |
DROPERIDOL |
Potassium Channel HERG |
85% |
.9272uM |
.7596uM |
View
|
androgen receptor |
HEXACHLOROPHENE |
Testosterone |
85% |
4.9753uM |
3.3169uM |
View
|
carbonic anhydrase 5a, mitochondrial |
ZINC CHLORIDE |
Carbonic Anhydrase |
85% |
1.159uM |
NoneNone |
View
|
carbonic anhydrase 3 |
ZINC CHLORIDE |
Carbonic Anhydrase |
85% |
1.159uM |
NoneNone |
View
|
carbonic anhydrase 2 |
ZINC CHLORIDE |
Carbonic Anhydrase |
85% |
1.159uM |
NoneNone |
View
|
carbonic anhydrase 4 |
ZINC CHLORIDE |
Carbonic Anhydrase |
85% |
1.159uM |
NoneNone |
View
|
carbonic anhydrase XI |
ZINC CHLORIDE |
Carbonic Anhydrase |
85% |
1.159uM |
NoneNone |
View
|
carbonic anhydrase IX |
ZINC CHLORIDE |
Carbonic Anhydrase |
85% |
1.159uM |
NoneNone |
View
|
carbonic anhydrase VIII |
ZINC CHLORIDE |
Carbonic Anhydrase |
85% |
1.159uM |
NoneNone |
View
|
carbonic anhydrase VII |
ZINC CHLORIDE |
Carbonic Anhydrase |
85% |
1.159uM |
NoneNone |
View
|
carbonic anhydrase VA, mitochondrial |
ZINC CHLORIDE |
Carbonic Anhydrase |
85% |
1.159uM |
NoneNone |
View
|
carbonic anhydrase IV |
ZINC CHLORIDE |
Carbonic Anhydrase |
85% |
1.159uM |
NoneNone |
View
|
carbonic anhydrase III, muscle specific |
ZINC CHLORIDE |
Carbonic Anhydrase |
85% |
1.159uM |
NoneNone |
View
|
carbonic anhydrase I |
ZINC CHLORIDE |
Carbonic Anhydrase |
85% |
1.159uM |
NoneNone |
View
|
carbonic anhydrase XIV |
ZINC CHLORIDE |
Carbonic Anhydrase |
85% |
1.159uM |
NoneNone |
View
|
carbonic anhydrase VB, mitochondrial |
ZINC CHLORIDE |
Carbonic Anhydrase |
85% |
1.159uM |
NoneNone |
View
|
carbonic anhydrase XII |
ZINC CHLORIDE |
Carbonic Anhydrase |
85% |
1.159uM |
NoneNone |
View
|
carbonic anhydrase VI |
ZINC CHLORIDE |
Carbonic Anhydrase |
85% |
1.159uM |
NoneNone |
View
|
carbonic anhydrase II |
ZINC CHLORIDE |
Carbonic Anhydrase |
85% |
1.159uM |
NoneNone |
View
|
Cytochrom P450-2D6 monooxygenase |
VALETHAMATE BROMIDE |
CYP450-2D6 Inhibition |
85% |
.2485uM |
NoneNone |
View
|
thromboxane A synthase 1 |
ZAFIRLUKAST |
Thromboxane Synthetase |
85% |
3.81uM |
NoneNone |
View
|
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) |
ZAFIRLUKAST |
Thromboxane Synthetase |
85% |
3.81uM |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 1A |
CINNARIZINE |
Serotonin 5-HT1A |
85% |
1.083uM |
.619uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
DILTIAZEM |
Calcium Channel Type L, Phenylalkylamine |
85% |
.63uM |
.612uM |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
DILTIAZEM |
Calcium Channel Type L, Phenylalkylamine |
85% |
.63uM |
.612uM |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
DILTIAZEM |
Calcium Channel Type L, Phenylalkylamine |
85% |
.63uM |
.612uM |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
DILTIAZEM |
Calcium Channel Type L, Phenylalkylamine |
85% |
.63uM |
.612uM |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
DILTIAZEM |
Calcium Channel Type L, Phenylalkylamine |
85% |
.63uM |
.612uM |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
DILTIAZEM |
Calcium Channel Type L, Phenylalkylamine |
85% |
.63uM |
.612uM |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
DILTIAZEM |
Calcium Channel Type L, Phenylalkylamine |
85% |
.63uM |
.612uM |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
DILTIAZEM |
Calcium Channel Type L, Phenylalkylamine |
85% |
.63uM |
.612uM |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
DILTIAZEM |
Calcium Channel Type L, Phenylalkylamine |
85% |
.63uM |
.612uM |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
DILTIAZEM |
Calcium Channel Type L, Phenylalkylamine |
85% |
.63uM |
.612uM |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
DILTIAZEM |
Calcium Channel Type L, Phenylalkylamine |
85% |
.63uM |
.612uM |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
DILTIAZEM |
Calcium Channel Type L, Phenylalkylamine |
85% |
.63uM |
.612uM |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
DILTIAZEM |
Calcium Channel Type L, Phenylalkylamine |
85% |
.63uM |
.612uM |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
DILTIAZEM |
Calcium Channel Type L, Phenylalkylamine |
85% |
.63uM |
.612uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
DILTIAZEM |
Calcium Channel Type L, Phenylalkylamine |
85% |
.63uM |
.612uM |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
DILTIAZEM |
Calcium Channel Type L, Phenylalkylamine |
85% |
.63uM |
.612uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
DILTIAZEM |
Calcium Channel Type L, Phenylalkylamine |
85% |
.63uM |
.612uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
DILTIAZEM |
Calcium Channel Type L, Phenylalkylamine |
85% |
.63uM |
.612uM |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
DILTIAZEM |
Calcium Channel Type L, Phenylalkylamine |
85% |
.63uM |
.612uM |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
DILTIAZEM |
Calcium Channel Type L, Phenylalkylamine |
85% |
.63uM |
.612uM |
View
|
Cytochrom P450-2D6 monooxygenase |
LABETALOL |
CYP450-2D6 Inhibition |
85% |
.8uM |
NoneNone |
View
|
Cytochrom P450-2C19 monooxygenase |
PHENYLHYDRAZINE |
CYP450-2C19 Inhibition |
85% |
5uM |
NoneNone |
View
|
A3 adenosine receptor |
IODOQUINOL |
Adenosine A3 |
85% |
.933uM |
.527uM |
View
|
phosphodiesterase 3B |
BITHIONOL |
Phosphodiesterase PDE3 |
85% |
2.723uM |
NoneNone |
View
|
phosphodiesterase 3A |
BITHIONOL |
Phosphodiesterase PDE3 |
85% |
2.723uM |
NoneNone |
View
|
dopamine receptor D3 |
BITHIONOL |
Dopamine D3 |
85% |
4.218uM |
1.433uM |
View
|
acetylcholinesterase (YT blood group) |
ETHYLESTRENOL |
Acetylcholinesterase |
85% |
6.504uM |
NoneNone |
View
|
collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase |
ETHYLESTRENOL |
Acetylcholinesterase |
85% |
6.504uM |
NoneNone |
View
|
acetylcholinesterase |
ETHYLESTRENOL |
Acetylcholinesterase |
85% |
6.504uM |
NoneNone |
View
|
synaptic vesicle glycoprotein 2b |
FENBENDAZOLE |
beta-Lactamase |
85% |
5.994uM |
NoneNone |
View
|
Sigma-2 Receptor |
BENZTROPINE |
Sigma2 |
85% |
.183uM |
.112uM |
View
|
adrenergic receptor, alpha 2a |
BENZTROPINE |
Imidazoline I2, Central |
85% |
1.925uM |
1.284uM |
View
|
adrenergic receptor, alpha 2c (Non-specific probe) |
BENZTROPINE |
Imidazoline I2, Central |
85% |
1.925uM |
1.284uM |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
OXYMETAZOLINE |
Calcium Channel Type L, Phenylalkylamine |
84% |
2.246uM |
2.184uM |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
OXYMETAZOLINE |
Calcium Channel Type L, Phenylalkylamine |
84% |
2.246uM |
2.184uM |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
OXYMETAZOLINE |
Calcium Channel Type L, Phenylalkylamine |
84% |
2.246uM |
2.184uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
OXYMETAZOLINE |
Calcium Channel Type L, Phenylalkylamine |
84% |
2.246uM |
2.184uM |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
OXYMETAZOLINE |
Calcium Channel Type L, Phenylalkylamine |
84% |
2.246uM |
2.184uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
OXYMETAZOLINE |
Calcium Channel Type L, Phenylalkylamine |
84% |
2.246uM |
2.184uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
OXYMETAZOLINE |
Calcium Channel Type L, Phenylalkylamine |
84% |
2.246uM |
2.184uM |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
OXYMETAZOLINE |
Calcium Channel Type L, Phenylalkylamine |
84% |
2.246uM |
2.184uM |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
OXYMETAZOLINE |
Calcium Channel Type L, Phenylalkylamine |
84% |
2.246uM |
2.184uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
OXYMETAZOLINE |
Calcium Channel Type L, Phenylalkylamine |
84% |
2.246uM |
2.184uM |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
OXYMETAZOLINE |
Calcium Channel Type L, Phenylalkylamine |
84% |
2.246uM |
2.184uM |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
OXYMETAZOLINE |
Calcium Channel Type L, Phenylalkylamine |
84% |
2.246uM |
2.184uM |
View
|
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
CADMIUM CHLORIDE |
Protein Tyrosine Kinase, HER2 Receptor |
84% |
1.334uM |
NoneNone |
View
|
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
CADMIUM CHLORIDE |
Protein Tyrosine Kinase, HER2 Receptor |
84% |
1.334uM |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
LACIDIPINE |
Calcium Channel Type L, Benzothiazepine |
84% |
.005449uM |
.004843uM |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
LACIDIPINE |
Calcium Channel Type L, Benzothiazepine |
84% |
.005449uM |
.004843uM |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
LACIDIPINE |
Calcium Channel Type L, Benzothiazepine |
84% |
.005449uM |
.004843uM |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
LACIDIPINE |
Calcium Channel Type L, Benzothiazepine |
84% |
.005449uM |
.004843uM |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
LACIDIPINE |
Calcium Channel Type L, Benzothiazepine |
84% |
.005449uM |
.004843uM |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
LACIDIPINE |
Calcium Channel Type L, Benzothiazepine |
84% |
.005449uM |
.004843uM |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
LACIDIPINE |
Calcium Channel Type L, Benzothiazepine |
84% |
.005449uM |
.004843uM |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
LACIDIPINE |
Calcium Channel Type L, Benzothiazepine |
84% |
.005449uM |
.004843uM |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
LACIDIPINE |
Calcium Channel Type L, Benzothiazepine |
84% |
.005449uM |
.004843uM |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
LACIDIPINE |
Calcium Channel Type L, Benzothiazepine |
84% |
.005449uM |
.004843uM |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
LACIDIPINE |
Calcium Channel Type L, Benzothiazepine |
84% |
.005449uM |
.004843uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
LACIDIPINE |
Calcium Channel Type L, Benzothiazepine |
84% |
.005449uM |
.004843uM |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
LACIDIPINE |
Calcium Channel Type L, Benzothiazepine |
84% |
.005449uM |
.004843uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
LACIDIPINE |
Calcium Channel Type L, Benzothiazepine |
84% |
.005449uM |
.004843uM |
View
|